Simplex Trading’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Simplex Trading’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-500	Closed	-$1K	–	10170
2023 Q2	$1K	Sell	500 -200	-29%	-$713	﹤0.01%	8783
2023 Q1	$2K	Sell	700 -49,300	-99%	-$228K	﹤0.01%	8582
2022 Q4	$251K	Buy	50,000 +6,600	+15%	+$41.4K	﹤0.01%	3941
2022 Q3	$567K	Buy	43,400 +2,200	+5%	+$33.3K	﹤0.01%	3326
2022 Q2	$528K	Buy	41,200 +38,700	+1,548%	+$536K	﹤0.01%	3372
2022 Q1	$38K	Sell	2,500 -21,500	-90%	-$335K	﹤0.01%	7515
2021 Q4	$425K	Buy	24,000 +22,100	+1,163%	+$424K	﹤0.01%	4042
2021 Q3	$39K	Buy	1,900 +1,500	+375%	+$33K	﹤0.01%	7838
2021 Q2	$7K	Buy	+400	New	+$9.36K	﹤0.01%	9324
2020 Q3	–	Sell	-1	Closed	-$1K	–	8717
2020 Q2	$1K	Buy	+1	New	+$19	﹤0.01%	7435

Simplex Trading's NGM Position: Q2 2024 in Review

Simplex Trading sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 28 shares.

Simplex Trading first reported a position in NGM in Q2 2020 and held it in 8 quarters. The position peaked at $243K in Q1 2021. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

Simplex Trading reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Simplex Trading sold 28 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024.
Simplex Trading first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 8 quarters.
Simplex Trading's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $243K in Q1 2021.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Simplex Trading's 13F filing for Q2 2024, filed 25 Jul 2024.